Follow The Filings

STOCK Act disclosures

ORMP Oramed Pharmaceuticals Inc.

Members of Congress who traded or hold Oramed Pharmaceuticals Inc., from their STOCK Act disclosures. None of the 13F managers we track hold it, so this page covers Congress only. ORMP earnings.

  • 1 members traded it since Nov 22, 2023
  • 0 / 1 buys / sales
  • 1 held it at year end (2025)
  • Jan 10, 2025 latest trade

Who holds it

Each member's latest annual report, with the value at year end in the range disclosed

  1. Brad Knott R-NC-13Self, 2025 $15K–$50K

Trades

1 trade since Nov 22, 2023, newest filings first

  1. Brad KnottR-NC-13House
    ORMPOramed Pharmaceuticals Inc.
    Sell
    $15K–$50K
    Traded Jan 10, 2025Filed Feb 25, 2025 46d

Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. See all Congress trades and how we read these reports.